ERBB2 and cancer: Studies show it stops growth and the invasion of various cancer types by suppressing inflammatory mediators involved in early-stage cancer, including LOX-2, COX-2, AP-1, TNF-α, epidermal growth factor receptor (EGFR), and human epidermal growth factor receptor-2 (HER2), given the close anti-inflammatory and antitumor links.